REPORTS OF SUSPECTED OPTIMARK SIDE EFFECTS / ADVERSE REACTIONS
Below is a sample of reports where side effects / adverse reactions may be related to Optimark. The information is not vetted and should not be considered as verified clinical evidence.
Possible Optimark side effects / adverse reactions in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-05
Patient: 58 year old female weighing 70.0 kg (154.0 pounds)
Reactions: Pruritus, Scab, Skin Burning Sensation, Skin Hyperpigmentation, Joint Stiffness, Anhedonia, Skin Swelling, Peau D'orange, Pain in Extremity, Skin Disorder, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Hypertrophy, Livedo Reticularis, Anxiety, Scar, Mobility Decreased, Skin Fibrosis
Suspect drug(s):
Magnevist
Indication: Imaging Procedure
Start date: 2005-05-26
End date: 2005-05-26
Contrast Media
Indication: Angiogram
Prohance
Indication: Imaging Procedure
Magnevist
Dosage: 15 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-05-30
Contrast Media
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-12-20
End date: 2003-12-20
Omniscan
Indication: Imaging Procedure
Optimark
Indication: Imaging Procedure
Multihance
Indication: Imaging Procedure
Other drugs received by patient: Phoslo; Folbee; Epogen; Colchicine; Calcitriol; Sensipar; Klonopin; Midodrine Hydrochloride; Plavix; Synthroid; Iron Supplement; Coumadin; Aspirin; Norvasc; Zemplar; Corticosteroids; Steroid Antibacterials; Levothyroxine Sodium; Nephrocaps; Renagel; Robaxin; Immunosuppressive Agents; Hormones and Related Agents; Neurontin; Gabapentin; Immunosuppressive Agents; Antithrombotic Agents
Possible Optimark side effects / adverse reactions in 31 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-06
Patient: 31 year old female weighing 59.8 kg (131.6 pounds)
Reactions: Pruritus, Pain, Joint Contracture, Skin Burning Sensation, Joint Stiffness, Generalised Oedema, Hand Deformity, Myalgia, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Skin Swelling, Pain in Extremity, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Stress, Skin Tightness, Anxiety, Arthralgia, Exfoliative Rash, Gait Disturbance, Atrophy
Suspect drug(s):
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2007-01-18
End date: 2007-01-18
Optimark
Indication: Angiogram
Prohance
Indication: Angiogram
Omniscan
Dosage: unk
Indication: Angiogram
Start date: 2003-01-10
End date: 2003-01-10
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-22
End date: 2003-09-22
Multihance
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging Brain
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Dilantin; Metoprolol Tartrate; Amlodipine; Phenytoin; Morphine; Renagel; Promethazine; Aspirin; Vitamin K TAB; Diazepam; Lovenox; Labetalol HCL; Lidocaine; Ibuprofen; Plendil; Coumadin; Heparin; Methadone HCL; Norvasc; Accupril; Vicodin; Depakote; Amiodarone HCL; Pravastatin; Enoxaparin; Cardura; Cardizem; Lamictal; Clonidine; Prednisone; Elavil
Possible Optimark side effects / adverse reactions in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10
Patient: 43 year old male weighing 118.0 kg (259.6 pounds)
Reactions: Pain in Extremity, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Depression, Fibrosis, Mobility Decreased, Scar
Adverse event resulted in: disablity
Suspect drug(s):
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: 20 ml, once
Start date: 2006-05-21
End date: 2006-05-21
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-04-25
End date: 2006-04-25
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Insulin [insulin]; Zemplar; Cardizem; Losartan Potassium; Albumin (Human); Aranesp; Phoslo; Catapres; Nephrocaps; Procardia XL; Procrit; Aldactone
|